Metropolitan Life Insurance Company (MetLife)’s Piedmont Lithium PLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,075
Closed -$14.3K 1567
2024
Q1
$14.3K Hold
1,075
﹤0.01% 2011
2023
Q4
$30.3K Hold
1,075
﹤0.01% 1715
2023
Q3
$42.7K Buy
1,075
+114
+12% +$5.54K ﹤0.01% 1497
2023
Q2
$55.5K Hold
961
﹤0.01% 1362
2023
Q1
$57.7K Sell
961
-136
-12% -$8.25K ﹤0.01% 1313
2022
Q4
$48.3K Hold
1,097
﹤0.01% 1498
2022
Q3
$58.7K Hold
1,097
﹤0.01% 1347
2022
Q2
$39.9K Buy
+1,097
New +$64.9K ﹤0.01% 1638

Other funds holding PLL

Metropolitan Life Insurance Company (MetLife)'s PLL Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Piedmont Lithium (PLL) in Q2 2024, closing a stake of 1,075 shares — an estimated $14.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PLL in Q2 2022 and held it in 8 quarters. The position peaked at $58.7K in Q3 2022. 122 funds tracked by Wall St. Rank hold PLL as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Piedmont Lithium position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,075 Piedmont Lithium shares in Q2 2024, an estimated $14.3K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Piedmont Lithium in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Piedmont Lithium position peaked at $58.7K in Q3 2022.
  • 122 funds tracked by Wall St. Rank held Piedmont Lithium as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.